Pharmaceutical M&A in Asia-Pacific: India and China Drive Regional Activity, but Japan Dominates High Value Transactions

Expanding healthcare coverage in emerging Asia-Pacific markets, rapid economic growth and burgeoning middle classes are attracting foreign M&A as companies attempt to offset future losses from the looming threat of the 2011 "patent cliff" and slowing growth in major developed markets. As these markets expand, consolidation of the domestic industry is also driving M&A in the Asia-Pacific region.

Scope

• Overview of the healthcare systems and pharmaceutical markets in key countries in Asia-Pacific.
• Overview of drivers, resistors and trends within the Asia-Pacific M&A landscape.
• Analysis of the types of acquisitions and healthcare sectors targeted.
• Analysis of geographic M&A activity and transaction values.

Contains 125 pages